NRG Therapeutics
ID: 6195213Drug discovery platform focused on restoring mitochondrial function through therapeutic approaches.
4
Funding Rounds
$104.7m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ne** Mi**** |
|
- |
Funding
Funding series
Funding Series Analysis
The company NRG Therapeutics has raised a total of $104.65m in funding over 4 rounds.
Key Insights:
- NRG Therapeutics Series B Round, September 2025: $67.5m
- NRG Therapeutics - Series A round, November 2022: $18.47m
- NRG Therapeutics November 2022 Series A Funding Round: $18m
- NRG Therapeutics August 2021 Seed Funding Round: $680k
Industries
NRG Therapeutics is active in the following industries: